W. Bauer

发表

It's time to bring the best and brightest back to gastroenterology.

W. Fackler, W. Bauer, K. Kongara, 1999, Gastroenterology.

Chemoprevention of colorectal cancer: slow, steady progress.

C. Burke, B. Lashner, W. Bauer, 2003, Cleveland Clinic journal of medicine.

Abnormal p53 Immunohistochemistry Is Associated With An Increased Colorectal Cancer–Related Mortality in Patients With Ulcerative Colitis

J. Goldblum, L. Rybicki, B. Lashner, 2003, American Journal of Gastroenterology.

Chronic respiratory distress, dyspepsia, and diarrhea: What is the connection?

J. Goldblum, D. Conwell, A. Lichtin, 1998, Journal of clinical gastroenterology.

Mesalamine for prophylaxis of small bowel Crohn’s disease recurrence

B. Lashner, W. Bauer, A. Brzezinski, 1999, Current gastroenterology reports.

Detection of Asymptomatic Ileal Carcinoid Tumors During Ileal Intubation at Screening Colonoscopy: A Case Series

J. Coombes, W. Bauer, J. Yarze, 2009, The American Journal of Gastroenterology.

Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.

J. Goldblum, L. Rybicki, B. Lashner, 2003 .

Case Report: Can Colectomy Cure Immune Thrombocytopenic Purpura in a Patient with Ulcerative Colitis?

B. Lashner, W. Bauer, A. Litchtin, 1999, Digestive Diseases and Sciences.

Implication of detecting mucosal dysplasia in a patient with ulcerative colitis. Authors' reply

W. Bauer, J. Yarze, R. Harty, 2002 .

Implication of detecting mucosal dysplasia in a patient with ulcerative colitis

W. Bauer, J. Yarze, M. P. Chase, 2002, American Journal of Gastroenterology.